Alireza Behrooz, Ph.D.

Washington, D.C. area
1900 Duke Street, Suite 600
Alexandria, VA 22314
D: 703.518.4524
Contact My Assistant
Agnieszka E. D'Alessio
D: 703.684.2512


Franklin Pierce Law Center - University of New Hampshire School of Law
    J.D., 2004

Case Western Reserve University
    Ph.D. Molecular Biology and Microbiology, 1998

Long Island University - Brooklyn
    M.S. Molecular and Cellular Biology, 1994

University of California - Los Angeles
    B.S. Mathematics Applied Science, 1991

Bar and Court Admissions

U.S. Patent and Trademark Office
District of Columbia Bar
Virginia Bar
Missouri Bar

Publications & Speaking

Matters of import: Parallel importation of pharmaceuticals in the US and Europe, IPPro Life Sciences, Issue 61, Pages 8-9 (2016)

IP Management 7: Biotechnological/Pharmaceutical Licensing, University of Washington School of Law, Center for Advanced Study and Research on Innovation Policy (CASRIP), Seattle, WA (Jul. 27, 2016)

Biosimilars: A Web of Complexity CLE (with K. Kowalchyk), Tarrytown, NY (Feb. 26, 2016)

Behrooz et al., “Stimulation of Glucose Transport by Hypoxia: Signals and Mechanisms,” News In Physiological Sci., 14:105-110 (1999)

Keri et al., “An NF-Y binding site is important for basal, but not gonadotropin-releasing hormone-stimulated, expression of the luteinizing hormone beta subunit gene, “ J. Biol. Chem., 275:13082-13088 (2000)

Chen et al., “Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia,” J. Biol. Chem., 276:9519-25 (2000)

Milliken et al., “Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice,” Endocrinology, 143:3671-3680 (2002)

Alireza Behrooz, Ph.D. is a registered patent attorney in Merchant & Gould’s Chemical & Life Sciences Group.  A former bench researcher and “gene jockey” in molecular biology, Alireza combines more than a decade of experience in intellectual property (IP) law with his in-depth knowledge of the life sciences to strategically secure and manage IP rights across a range of industries that includes the biotechnology & life sciences as well as the agriculture/crop science industry, medical devices, oral and personal care products, and animal health & nutrition. Over the years, he has assisted both small and large companies with their IP portfolios/assets to best achieve their business objectives and to address the particular IP challenges facing the specific industry.